63 related articles for article (PubMed ID: 35339615)
1. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis.
Zheng X; Du Y; Liu M; Wang C
Funct Integr Genomics; 2023 Jun; 23(2):196. PubMed ID: 37270717
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway.
Guo JH; Ma YS; Lin JW; Jiang GX; He J; Lu HM; Wu W; Diao X; Fan QY; Wu CY; Liu JB; Fu D; Hou LK
Br J Cancer; 2023 Aug; 129(2):366-373. PubMed ID: 37179440
[TBL] [Abstract][Full Text] [Related]
3. Every step of the way: integrins in cancer progression and metastasis.
Hamidi H; Ivaska J
Nat Rev Cancer; 2018 Sep; 18(9):533-548. PubMed ID: 30002479
[TBL] [Abstract][Full Text] [Related]
4. EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.
Wang J; Wren JD; Ding Y; Chen J; Mittal N; Xu C; Li X; Zeng C; Wang M; Shi J; Zhang YH; Han SJ; Zhang XA
Cancer Lett; 2022 Jun; 536():215641. PubMed ID: 35339615
[TBL] [Abstract][Full Text] [Related]
5. EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.
Ding Y; Chen J; Li S; Wren JD; Bajpai AK; Wang J; Tanaka T; Rice HC; Hays FA; Lu L; Zhang XA
Oncogene; 2023 Mar; 42(12):861-868. PubMed ID: 36788350
[TBL] [Abstract][Full Text] [Related]
6. EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation.
Fu C; Wang J; Pallikkuth S; Ding Y; Chen J; Wren JD; Yang Y; Wong KK; Kameyama H; Jayaraman M; Munshi A; Tanaka T; Lidke KA; Zhang XA
Cell Mol Life Sci; 2022 Jun; 79(7):389. PubMed ID: 35773608
[TBL] [Abstract][Full Text] [Related]
7. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.
Zhang Z; Wang H; Ding Q; Xing Y; Xu D; Xu Z; Zhou T; Qian B; Ji C; Pan X; Zhong A; Ying Z; Zhou C; Shi M
Biomed Pharmacother; 2017 May; 89():1055-1060. PubMed ID: 28292013
[TBL] [Abstract][Full Text] [Related]
9. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
10. TFE3 Regulates the Function of the Autophagy-Lysosome Pathway to Drive the Invasion and Metastasis of Papillary Thyroid Carcinoma.
Lu H; Zhu C; Ruan Y; Fan L; Wei K; Yang Z; Chen Q
Anal Cell Pathol (Amst); 2021; 2021():3081491. PubMed ID: 34660181
[TBL] [Abstract][Full Text] [Related]
11. EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.
Fu C; Zhang Q; Wang A; Yang S; Jiang Y; Bai L; Wei Q
Mol Oncol; 2021 May; 15(5):1543-1565. PubMed ID: 33605506
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Review of Web Servers and Bioinformatics Tools for Cancer Prognosis Analysis.
Zheng H; Zhang G; Zhang L; Wang Q; Li H; Han Y; Xie L; Yan Z; Li Y; An Y; Dong H; Zhu W; Guo X
Front Oncol; 2020; 10():68. PubMed ID: 32117725
[TBL] [Abstract][Full Text] [Related]
13. Novel Analytical Platform For Robust Identification of Cell Migration Inhibitors.
Somchai P; Phongkitkarun K; Kueanjinda P; Jamnongsong S; Vaeteewoottacharn K; Luvira V; Okada S; Jirawatnotai S; Sampattavanich S
Sci Rep; 2020 Jan; 10(1):931. PubMed ID: 31969633
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]